Tagged diabetes
Press Release
Modular Medical Announces BSI Group as Trusted Body for CE Mark Clearance
- Engaged BSI Group to start the process of obtaining regulatory clearance of the MODD1, next-generation insulin pump for the European market
- Targeting Q1 2026 for expected clearance of the MODD1 in the E.U.
Read More
Press Release
Modular Medical Announces Licensing and Partnership Agreement With Nudge BG
-Modular Medical will collaborate with Nudge BG to bring to market an adaptive full closed loop Automated Insulin Delivery system that does not require mealtime announcements
-Effort will be led be Nudge BG founder and noted AID expert, Lane Desborough
Read More
Press Release
Ankle & Foot Centers of America Highlights Vital Role of Podiatric Care for People with Diabetes
During National Diabetes Awareness Month, the major multi-state podiatry group emphasizes how its advanced vascular care for diabetic foot complications can prevent severe complications and help patients maintain their mobility and way of life.
Read More
Press Release
The Lifesciences Magazine’s New Issue Features the Most Innovative Biopharma Company Targeting Diabetes in 2024
Lifesciences Magazine: Battling Diabetes! Exclusive Interview with the Glen Travers (Co-founder of Diabetology Limited), Leading Biopharma Company Pushing Boundaries Read More
Press Release
Seraxis Wins Maryland Stem Cell Research Fund Grant to Accelerate Development of Allogenetically Compatible Pancreatic Islet Replacement Therapy for Functional Cure of T1D
$400,000 award will support characterization and efficacy testing of preclinical SR-03 cell line as a part of IND development. Seraxis is taking meetings at the American Diabetes Association Annual Meeting in Orlando, June 21-24. Read More
Press Release
Seraxis’ Manufacturing Suite Completes GMP Quality System Audit Ahead of SR-02 IND Filing and Transplantation of Pancreatic Clusters to Patients With Type 1 Diabetes
GMP-compliant manufacturing puts SR-02 on track to be industry’s second clinical-stage stem cell derived pancreatic islet transplant program. The third-party auditor’s FDA six-system approach yielded no critical nor major observations of Seraxis’ quality system for the production of GMP-grade organs from pancreas-derived stem cells. Dr. William Rust, CEO, will present further data on the development of SR-02 and follow-on immune-cloaked SR-03 on Monday, January 8 at 10:30 a.m. PST at Biotech Showcase in San Francisco. Read More
Press Release
Ananda Professional Unveils GluNOzym™ + Reducose® - a Breakthrough Solution for Balanced Blood Sugar and Healthy Weight Management
Ananda Professional unveils GluNOzym™ + Reducose®, a revolutionary product designed to redefine blood sugar management and support healthy weight. Combining innovative ingredients, including clinically researched Reducose®, this groundbreaking single-gummy solution blocks sugars and starches from turning into blood glucose. Backed by impressive clinical data, GluNOzym™ emerges as a game-changer in the wellness industry. Read More
Press Release
Seraxis Announces Publication of Preclinical Data for a Novel Islet Replacement Therapy and Clinical Candidate SR-02 for Insulin-Requiring Diabetes; Oral Presentation at IPITA
Manuscript describes the unique character of a pancreatic endocrine cell population derived from a non-pluripotent stem cell that closely resembles native islets in composition and in vivo function. Dr. William Rust, CEO of Seraxis, will deliver a lecture at the IPITA-IXA-CTRMS Joint Congress on October 29 at 10:00 a.m. in San Diego entitled “Novel stem cell-derived islet-like clusters potently control rodent blood glycemia”. Seraxis will be taking meetings at BIO-Europe, November 6-8, in Munich. Read More
Press Release
Seraxis to Provide Oral Update on Its Pancreatic Organoid Candidate for Functional Cure of T1D at the 59th Annual Meeting of the EASD
Dr. William Rust will give an oral presentation on Seraxis’ proprietary technology for the production of therapeutic pancreatic organoids from pancreas-derived stem cells, as well as review initial diabetes model data of functional cure of Type 1 Diabetes. Seraxis’ presentation, entitled “Stem-cell Derived Islets for Treating Diabetes”, will be delivered in the session entitled "Transplantation of Islet and Stem Cells Today and Tomorrow". Read More
Press Release
Seraxis Announces Closing of Second VC Tranche and Successful Completion of Preclinical Studies of Pancreatic Organoids From Seraxis’ Novel Pancreas-Derived Stem Cells
Leadership team expanded with addition of Chief Corporate Development Officer, Ted Hibben, a 25-year venture-stage business development biotherapeutic industry veteran Total venture funding tops $50M to date Read More
Press Release
SweetLeaf Partners With the American Diabetes Association in the Fight Against Diabetes
The SweetLeaf and American Diabetes Association partnership will promote healthy alternatives to sugar, drive awareness of diabetes risk and management and help diabetics take action to improve their health. Read More
Press Release
PolarSeal Announces Wearable Medical Device Solutions in the US to Change Outcomes for 88 Million People at Risk for Type 2 Diabetes
PolarSeal Tapes and Conversions, a leading contract medical device manufacturer and adhesive converter, will now provide cost-effective and bespoke solutions for US' wearable medical device market. Read More
Press Release
Happy Bob Integrates With Dexcom CGM to Provide a Playful Way to Engage With Real-Time Glucose Values and Improve Overall Self-Care
Happy Bob App offers Dexcom CGM users and their caregivers more ways to interact with their glucose data, including a real-time iOS widget, Apple Watch app, groups, gamification, and humorous personalized messages. Read More
Press Release
SNAQ Launches their Diabetes Management App in the US and Adds Leading Experts to the Advisory Board
After the success in Europe, the award-winning SNAQ App is now available for people living with diabetes in the United States. The app supports seamless integration with many popular glucose sensors and diabetes apps. Alongside this launch, Anton Kittelberger, Dr. David Kerr and John Sjolund are newly joining the Advisory Board of SNAQ. Read More
Press Release
ExpressionMed CEO & Founder, Thiel Fellow, Meghan Sharkus Celebrates Five Years of Successful Business
What started as an idea to build confidence for a close friend with diabetes has grown over the past five years into a multi-million-dollar company with a mission to improve the quality of life for CGM wearers. Read More
Press Release
Pharmacy Quality Solutions and Humana Achieve Noteworthy Success in Diabetes Outcomes Pilot, Catalyzing Program Expansion
Humana and PQS to expand EQuIPP® platform-based program regionally in 2021, enabling more pharmacists to provide enhanced support to patients in managing their diabetes goals Read More
Press Release